Personalized, parcel‐guided rTMS for the treatment of major depressive disorder: Safety and proof of concept
Tang S, Holle J, Dadario N, Lesslar O, Teo C, Ryan M, Sughrue M, Yeung J. Personalized, parcel‐guided rTMS for the treatment of major depressive disorder: Safety and proof of concept. Brain And Behavior 2023, 13: e3268. PMID: 37798655, PMCID: PMC10636393, DOI: 10.1002/brb3.3268.Peer-Reviewed Original ResearchConceptsRepetitive transcranial magnetic stimulationQuality of lifeBeck Depression InventoryTreatment-resistant depressionComorbidity of depressionMajor depressive disorderTranscranial magnetic stimulationMultiple cortical targetsDorsolateral prefrontal cortexRTMS treatmentSignificant remissionRetrospective reviewDepressive disorderPatient outcomesCortical targetsMagnetic stimulationPlacebo effectPatientsUS FoodDrug AdministrationControl groupDepression symptomsDepression InventoryFunctional connectivity networksPrefrontal cortex